Antibiotic resistance profile & extended spectrum beta-lactamase (ESBL) production in Acinetobacter species

Indian Journal of Medical Research

Volumn 126, Issue 1, 2007, Pages 63-67

  Sinha, Mahua ^a   Srinivasa, H ^a   Macaden, R ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Acinetobacter; Extended spectrum beta lactamase (ESBL)

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM; PIPERACILLIN; SULPERAZON; BETA LACTAMASE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER JUNII; ACINETOBACTER LWOFFII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME SYNTHESIS; GENUS; INDIA; NONHUMAN; PHENOTYPE; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; MICROBIOLOGICAL EXAMINATION;

ACINETOBACTER; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS;

EID: 35548980351     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bergogne-Berezin E, Towner KJ. Acinetobacter species as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Micro Rev 1999; 9: 148-65.
2. Gerner-Smidt P, Frederiksen W. Acinetobacter in Denmark. I. Taxonomy, antibiotic susceptibility, and pathogenicity of 112 clinical strains. Acta Pathol Microbiol Immunol Scand 1993; 101: 815-25.
3. Prashant K, Badrinath S. Simplified phenotypic tests for identification of Acinetobacter spp. and their antimicrobial susceptibility status. J Med Microbiol 2000; 49: 773-8.
4. Gulati S, Kapil A, Goel V, Das B, Dwivedi SN, Mahapatra AK. Biotyping of Acinetobacter spp. isolated from clinical samples. Indian J Med Res 1999; 110: 160-3.
5. Vahaboglu H, Coskunkan F, Tansel O, Ozturk R, Sahin N, Koksal I, et al. Clinical importance of extended-spectrum ß- lactamase (PER-1-type)-producing Acinetobacter spp. and P. aeruginosa strains. J Med Microbiol 2001; 50: 642-5.
6. Joshi SG, Litake GM, Ghole VS, Niphadkar KB. Plasmid borne extended spectrum β lactamase in a clinical isolate of Acinetobacter baumannii. J Med Microbiol 2003; 52: 1125-7.
7. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended- spectrum ß-lactamase VEB-1 producing isolates of Acinetobacter baumannii in a French Hospital. J Clin Microbiol 2003; 41: 3542-7.
8. Yong D, Shin JH, Kim S, Lim Y, Yum JH, Lee K, et al. High prevalence of PER- 1 extended-spectrum b-lactamase-producing Acinetobacter spp. in Korea. Antimicrob Agents Chemother 2003; 47: 1749-51.
9. Bauer AW, Kirby W, Sherris J, Turck M. Antibiotic susceptibility testing by a standard single disc method. Am J Clin Pathol 1966; 45: 493-6.
10. Swenson JM, Killgore GE, Tenover FC. Antimicrobial sensitivity testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods. J Clin Microbiol 2004; 42: 5102-8.
11. Bradford PA. Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
12. Jain A, Roy I, Gupta M, Kumar M, Agarwal S. Prevalence of extended-spectrum β-lactamases producing Grain-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 2003; 52: 421-5.
13. Dutta P, Thakur A, Mishra B, Gupta V. Comparison of double disc and three dimensional methods to screen for ESBL producers in a tertiary care hospital. Jpn J Infect Dis 2004; 57: 146-9.
14. Menon T, Bindu D, Kumar CPG, Nalini S, Thirunarayan MA. Comparison of double disc and three dimensional methods to screen for ESBL producers in a tertiary care hospital. Indian J Med Microbiol 2006; 24: 117-20.